2019-01-08
On the afternoon of January 8th, the Dahuanong Business Division held the 2018 Annual Work Summary and Cadre Conference in the multi-function hall on the second floor of the company's office building. Attending the meeting were Chen Ruiai, Vice President of the Group and President of the Dahuanong Business Division, Fang Binghu, Vice President of the Dahuanong Business Division, and directors at the level or above of the Dahuanong Business Division, all staff of the functional departments, and employees with a master's degree or above, totaling 170 people. Wen Xiaoqiong, Executive Vice President of the Group, attended the meeting to provide important guidance.
Shen Chong, Deputy General Manager of the Financial Information Department of the Dahuanong Business Division, presented the "2018 Financial Summary Report and 2019 Budget of the Dahuanong Business Division," and Wang Aiming, General Manager of the Biological Drug Company, presented the "2018 Work Summary and Key Points of 2019 Work of the Dahuanong Business Division." The annual report pointed out that in 2018, the Dahuanong Business Division took technological innovation as the breakthrough point for competitiveness, and the technical competitive advantage is taking shape; it strengthened risk prevention and system innovation, further improving corporate control levels; innovated market marketing models to promote external market growth; promoted engineering construction and new project cooperation, laying a capacity foundation for subsequent development; deeply studied and practiced Wens Foodstuffs culture, enhancing the corporate social image. In the new year, the Dahuanong Business Division will take "innovative breakthroughs to strengthen advantages, increase efficiency, and promote development" as the main line of work, solidly do a good job in various business operations, effectively promote the Dahuanong Business Division's revitalization plan, and lay a good foundation for the start of the "Fifth Five-Year Plan."
At the meeting, Chen Ruiai summarized the highlights and effectiveness of the Dahuanong Business Division's work in 2018, analyzed the situation of the animal protection industry in 2019, as well as the opportunities and challenges encountered, and deployed key work for 2019. She pointed out that in 2018, under the correct guidance and help of the group, and with the joint efforts of all cadres and employees, the Dahuanong Business Division mainly achieved the following five aspects of work effectiveness: first, by strongly grasping market opportunities and adjusting strategies in a timely manner, the economic targets for the whole year were fully completed; second, scientific and technological innovation has created a good situation, and a number of new products and new business income have been obtained; third, by strengthening internal control management, controlling costs, stabilizing quality, ensuring safe supply and safe sales; fourth, actively tracking and researching African swine fever prevention and control technology, actively developing a variety of disinfectants, providing product support for the group to win the battle against African swine fever; fifth, by leveraging organizational advantages, integrating the strength of the business division and the fourth-level units, strengthening management, and improving performance appraisal management level. Chen Ruiai emphasized that 2019 is an innovative year for the Dahuanong Business Division's animal protection industry, with opportunities greater than challenges. The Dahuanong Business Division will closely focus on the main line of "innovative breakthroughs to strengthen advantages, increase efficiency, and promote development," and focus on improving the following five aspects of work effectiveness: first, improving the management efficiency and performance appraisal management level of the fourth-level operating units; second, improving the ability and level of functional departments to focus on key work, professional work, and efficiency work, to help complete business tasks and promote the development of the Dahuanong Business Division's animal protection industry; third, improving the level of market sales strategy research, enhancing the adaptability and competitiveness of the Dahuanong Business Division's animal protection industry in response to the transformation and upgrading of the breeding industry; fourth, enhancing the sense of urgency and effectiveness of R&D innovation work; fifth, enhancing the sense of responsibility and responsibility of cadres for the cause, and cadres should cherish their post honors and become cadres who are truly dedicated to their careers.
At the meeting, Wen Xiaoqiong, the Executive Vice President of the Group, affirmed the achievements made by the Dahuanong Business Division in 2018 and summarized the work of the Dahuanong Business Division in 2018 from two aspects of quantification and qualification. She pointed out that from the perspective of quantified indicators, the Dahuanong Business Division achieved beautiful performance in 2018 in terms of revenue, profit completion rate, per capita efficiency, new product revenue, and foreign sales growth; it could timely and accurately implement the management ideas, concepts, policies, and policies proposed by the group company, and the work was well connected with the various functional departments of the group. Wen Xiaoqiong emphasized that in 2019, the Dahuanong Business Division should do a good job in the following two aspects: first, it should stabilize the current production and operation performance and industry status; second, it should look forward, increase R&D efforts, and ensure high-quality growth in operating performance. At the meeting, Wen Xiaoqiong also fully affirmed the role of the Dahuanong Business Division in providing epidemic prevention and control guarantees for the group's large-scale production, stabilizing the prices of drug and vaccine products, enhancing the group company's corporate image and influence, and contributing to profits.
The meeting commended the outstanding employees of the Dahuanong Business Division for 2018. Finally, Zhaoqing Dahuanong Company, Foshan Standard Company, Xinxing Biological Drug Branch Company, Xinxing Chemical Drug Branch Company, and Additive Branch Company reported their work for 2019 in turn.